iNova Pharmaceuticals continues its growth trajectory in Asia with the launch of DURO-TUSS®, a science-backed cough range that joins the company’s leading product portfolio in The Philippines.
The expert-formulated range was officially launched at a medical event held at Shangri-La The Fort, Manila, attended by more than 120 healthcare professionals. The launch marks a key milestone in iNova’s commitment to expanding access to evidence-based respiratory care across Asia.
Reflecting on the launch, Country Manager of iNova Philippines, Elena Lam shared, “As the company behind household health brands like Difflam® and BETADINE®, we’re proud to introduce DURO-TUSS® to the Philippines. This launch reflects our promise to support Filipino health with trusted, clinically backed solutions.”
The event featured a Continuing Medical Education (CME) program that explored the local burden of cough, current treatment approaches, and global data supporting DURO-TUSS®’ active ingredients. It also provided a valuable opportunity to connect with healthcare professionals and share insights on respiratory care.
With a strong legacy and a clear focus on innovation, DURO-TUSS® is now available at leading pharmacies nationwide. It carries a comprehensive range of prescription and over-the-counter cough relief medications tailored to treat either dry cough or cough with phlegm.
Always read the label and follow directions for use. Consult your doctor if symptoms persist.
